Related Experiment Video
Updated: Aug 8, 2026
Analysis of Cardiomyocyte Development using Immunofluorescence in Embryonic Mouse Heart
Published on: March 26, 2015
Ultrastructural distribution of the S100A1 Ca2+-binding protein in the human heart
B Maco1, A Mandinova, M B Dürrenberger
1Institute of Molecular Physiology and Genetics, Slovak Academy of Sciences, Bratislava.
Insights
S100A1 protein, implicated in heart conditions, is found in human heart cells. Its distribution within the sarcoplasmic reticulum and myofibrils suggests a role in calcium regulation and cardiac function.
Area of Science:
- Cardiovascular Biology
- Cellular Ultrastructure
- Protein Localization
Background:
- Calcium (Ca2+) homeostasis is crucial for cardiac function; disruptions are linked to cardiomyopathies.
- S100A1 protein, a Ca2+-binding protein, is a potential player in cardiac pathological processes.
- Understanding S100A1's precise location in heart cells is key to elucidating its role.
Purpose of the Study:
- To quantitatively determine the ultrastructural localization of S100A1 protein in human heart muscle.
- To identify specific cellular compartments where S100A1 is concentrated.
- To correlate S100A1 distribution with its known or potential target proteins in cardiac cells.
Main Methods:
- Postembedding immunocytochemistry using Lowicryl K4M embedding.
- Quantitative analysis of S100A1 antigen site density per unit area.
- Microscopic examination of human heart muscle tissue.
Main Results:
- S100A1 protein was detected in the sarcoplasmic reticulum (SR), myofibrils (all sarcomere levels), and mitochondria.
- Immunolabeling density for S100A1 was significantly higher at Z-lines (approx. 3x) and SR (approx. 5x) compared to other components.
- High S100A1 concentration in SR and myofibrils aligns with known target protein locations.
Conclusions:
- S100A1 is precisely localized within key functional compartments of human cardiomyocytes.
- The abundance of S100A1 in SR and myofibrils supports its involvement in calcium handling and sarcomeric function.
- These findings provide a structural basis for S100A1's role in normal and potentially pathological cardiac conditions.
Abstract:
Impaired calcium homeostasis and altered expression of Ca2+-binding proteins are associated with cardiomyopathies, myocardial hypertrophy, infarction or ischemia. S100A1 protein with its modulatory effect on different target proteins has been proposed as one of potential candidates which could participate in these pathological processes. The exact localization of S100A1 in human heart cells on the ultrastructural level accompanied with biochemical determination of its target proteins may help clarify the role of S100A1 in heart muscle. In the present study the distribution of the S100A1 protein using postembedding (Lowicryl K4M) immunocytochemical method in human heart muscle has been determined quantitatively, relating number of antigen sites to the unit area of a respective structural component. S100A1 antigen sites have been detected in elements of sarcoplasmic reticulum (SR), in myofibrils at all levels of sarcomere and in mitochondria, the density of immunolabeling at Z-lines being about 3 times and at SR more than 5 times higher than immunolabeling of remaining structural components. The presence of the S100A1 in SR and myofibrils may be related to the known target proteins for S100A1 at these sites.
